Impending challenges of the burden of end-stage kidney disease in Australia

Wai H. Lim, David W. Johnson, Stephen P. McDonald, Carmel Hawley, Philip A. Clayton, Matthew D. Jose, Germaine Wong

Research output: Contribution to journalReview articlepeer-review

11 Citations (Scopus)


Sex and age-specific incidence rates of patients with treated end-stage kidney disease (ESKD) in Australia are comparable to those in European countries, but substantially lower compared with those in the United States, Canada and many Asian countries. The incidence rates of treated ESKD in Australia increase with advancing age; however, the incidence of ESKD is likely to be underestimated because a proportion of patients with ESKD (about 50%) remain untreated. Late referral to nephrologists has reduced over the past decade, temporally associated with improved ESKD recognition. However, late referral still occurs in one in five Australians with ESKD. One in two Australians with ESKD has diabetes, with up to 35% of cases directly attributed to diabetes. Mortality rates for patients with ESKD remain substantially higher compared with the age-matched general population, although there has been a significant improvement in survival over time. Cardiovascular disease and cancer are the two most common causes of death in patients with ESKD.

Original languageEnglish
Pages (from-to)374-380.e3
Number of pages10
JournalMedical Journal of Australia
Issue number8
Publication statusPublished - 1 Oct 2019
Externally publishedYes


Dive into the research topics of 'Impending challenges of the burden of end-stage kidney disease in Australia'. Together they form a unique fingerprint.

Cite this